Matthew Z Guo

6PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

|May 23, 2025
A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma.

Parul Agarwal, Matthew Guo, Kabeer Munjal

|May 03, 2023
Adagrasib: a novel inhibitor for <i>KRAS</i>-mutated non-small-cell lung cancer.

Matthew Z Guo, Kristen A Marrone, Alexander Spira

|Feb 08, 2022
Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis.

Catalina Pereira, Gerardo A Arroyo-Martinez, Matthew Z Guo

|Dec 02, 2021
Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics.

Matthew Z Guo, Kristen A Marrone, Alexander Spira

|Apr 30, 2021
Targeting Cancer Stem Cells with Differentiation Agents as an Alternative to Genotoxic Chemotherapy for the Treatment of Malignant Testicular Germ Cell Tumors.

Amanda R Loehr, Timothy M Pierpont, Eric Gelsleichter

Pageof 1

Frequent Collaborators

2 joint publications

Robert S Weiss

2 joint publications

Anna K Ferguson

2 joint publications

Daniel Laheru

2 joint publications

Mark Yarchoan